Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial

Affiliations

• ¹ Department of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
• ² Department of Nephrology, Sorbonne Université, Pitié-Salpêtrière Hospital, Paris, France.
• ³ Centre of Integrative Chinese Medicine, Sorbonne University, Pitié-Salpêtrière Hospital, Paris, France.
• ⁴ Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
• ⁵ Department of Clinical Research, National Cancer Institute, Boulogne-Billancourt, France.
• ⁶ Department of Nephrology, Sorbonne University, Hospital Tenon, Paris, France.
• ⁷ Department of Nephrology, The First People's Hospital of Changzhou, Changzhou, China.
• ⁸ Department of Nephrology, The First People's Hospital of Xuzhou, Xuzhou, China.
• ⁹ Department of Nephrology, Wuxi People's Hospital, Wuxi, China.
• ¹⁰ Department of Nephrology, Affiliated Hospital of Nantong University, Nantong, China.
• ¹¹ Department of Pharmacy, Sorbonne University, Pitié Salpêtrière, Paris, France.
• ¹² Department of Nephrology, Taizhou Hospital of Traditional Chinese Medicine, Taizhou, China.
• ¹³ Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, China.
• ¹⁴ Department of Endocrinology, Zhongda Hospital, Southeast University, Nanjing, China.
• ¹⁵ Department of Nephrology, Changzhou Hospital of Traditional Chinese Medicine, Changzhou, China.
• ¹⁶ Department of Biochemistry - Hormonology, Sorbonne University, Hospital Tenon, Paris, France.
• ¹⁷ School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.